Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances
Tóm tắt
Từ khóa
Tài liệu tham khảo
Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; sixteenth informational supplement. CLSI document M100-S16CLSI, Wayne, PA (2006).
European Committee for Antimicrobial Susceptibility Testing (EUCAST) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID). Determination of minimum inhibitory concentrations (MICs) of antibacterial agents by broth dilution. Clin. Microbiol. Infect. 9, ix–xv (2003).
Kahlmeter, G. et al. European harmonization of MIC breakpoints for antimicrobial susceptibility testing of bacteria. J. Antimicrob. Chemother. 52, 145–148 (2003).
Nanavaty, J., Mortensen, J.E. & Shryock, T.R. The effects of environmental conditions on the in vitro activity of selected antimicrobial agents against Escherichia coli. Curr. Microbiol. 36, 212–215 (1998).
D'amato, R.F., Thornsberry, C., Baker, C.N. & Kirven, L.A. Effect of calcium and magnesium ions on the susceptibility of Pseudomonas species to tetracycline, gentamicin polymyxin B, and carbenicillin. Antimicrob. Agents Chemother. 7, 596–600 (1975).
Rhomberg, P.R., Sader, H.S. & Jones, R. Reproducibility of daptomycin MIC results using dry-form commercial trays with appropriate supplemental calcium content. Int. J. Antimicrob. Agents 25, 274–276 (2005).
Bowdish, D.M., Davidson, D.J. & Hancock, R.E. A re-evalution of the role of host defence peptides in mammalian immunity. Curr. Protein Pep. Sci. 6, 35–51 (2005).
Hancock, R.E. & Sahl, H.G. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat. Biotechnol. 24, 1551–1557 (2006).
Chambers, H.F. & Hackbarth, C.J. Effect of NaCl and nafcillin on penicillin-binding protein 2a and heterogeneous expression of methicillin resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 31, 1982–1988 (1987).
Ferguson, R.W. & Weissfeld, A.S. Comparison of the suitability of three common bacterial media for susceptibility testing of trimethoprim-sulfamethoxazole. Clin. Microbiol. 19, 85–86 (1984).
Bradford, P.A. et al. Tigecycline MIC testing by broth dilution requires use of fresh medium or addition of the biocatalytic oxygen-reducing reagent oxyrase to standardize the test method. Antimicrob. Agents Chemother. 49, 3903–3909 (2005).
Thomson, K.S. & Moland, E.S. Cefepime, piperacillin-tazobactam, and the inoculum effect in tests with extended-spectrum beta-lactamase-producing Enterobacteriaceae. Antimicrob. Agents Chemother. 45, 3548–3554 (2001).
Granier, S.A. et al. False susceptibility of Klebsiella oxytoca to some extended-spectrum cephalosporins. J. Antimicrob. Chemother. 50, 303–304 (2002).
Pankey, G.A. & Sabath, L.D. Clinical relevance of bacteriostatic versus bactericidal mechanisms of action in the treatment of Gram-positive bacterial infections. Clin. Infect. Dis. 38, 864–870 (2004).
Biedenbach, D.J., Schermer, I.H. & Jones, R.N. Validation of Etest for seven antimicrobial agents using regulatory criteria for the assessment of antimicrobial susceptibility devices. Diagn. Microbiol. Infect. Dis. 27, 1–5 (1997).
Andrews, J.M. & Wise, R. Comparison of the Etest with a conventional agar dilution method in evaluating the in vitro activity of moxifloxacin. J. Antimicrob. Chemother. 45, 257–258 (2000).
Steward, C.D. et al. Antimicrobial susceptibility testing of carbapenems: multicenter validity testing and accuracy levels of five antimicrobial test methods for detecting resistance in Enterobacteriaceae and Pseudomonas aeruginosa isolates. J. Clin. Microbiol. 41, 351–358 (2003).
Biedenbach, D.J. & Jones, R.N. Comparative assessment of Etest for testing susceptibilities of Neisseria gonorrhoeae to penicillin, tetracycline, ceftriaxone, cefotaxime, and ciprofloxacin: investigation using 510(k) review criteria, recommended by the Food and Drug Administration. J. Clin. Microbiol. 34, 3214–3217 (1996).
Di Bonaventura, G. et al. Comparison of Etest, agar dilution, broth microdilution and disk diffusion methods for testing in vitro activity of levofloxacin against Staphylococcus spp. isolated from neutropenic cancer patients. Int. J. Antimicrob. Agents. 19, 147–154 (2002).
Fritsche, T.R., Rennie, R.P., Goldstein, B.P. & Jones, R.N. Comparison of dalbavancin MIC values determined by Etest (AB BIODISK) and reference dilution methods using gram-positive organisms. J. Clin. Microbiol. 44, 2988–2990 (2006).
Sader, H.S., Fritsche, T.R. & Jones, R.N. Accuracy of three automated systems (MicroScan WalkAway, VITEK, and VITEK 2) for susceptibility testing of Pseudomonas aeruginosa against five broad-spectrum beta-lactam agents. J. Clin. Microbiol. 44, 1101–1104 (2006).
Wiegand, I. et al. Detection of extended-spectrum beta-lactamases among Enterobacteriaceae by use of semiautomated microbiology systems and manual detection procedures. J. Clin. Microbiol. 45, 1167–1174 (2007).
Andrews, JM. Determination of minimum inhibitory concentrations. J. Antimicrob. Chemother. 48 (suppl. 1): 5–16 (2001).
Steinberg, D.A., Hurst, M.A., Fujii, C.A., Kung, A.H., Ho, J.F., Cheng, F.C., Loury, D.J. & Fiddes, J.C. Protegrin-1: a broad-spectrum, rapidly microbial peptide with in vivo activity. Antimicrob. Agents Chemother. 41, 1738–1742 (1997).
Wick, WE. Influence of antibiotic stability on the results of in vitro testing procedures. J. Bacteriol. 87, 1162–1170 (1964).
Wiegand, I. & Wiedemann, B. Microbial resistance to drugs. In Encyclopedic Refererence of Molecular Pharmacology (eds. Offermanns, S. & Rosenthal, W.) 594–600 (Springer-Verlag, Berlin Heidelberg, 2003).
Ericsson, HM & Sherris, JC. Antibiotic sensitivity testing. Report of an international collaborative study. Acta. Pathol. Microbiol. Scand. B. 217 (suppl.), 1–90 (1971).